Are there specific resources for people of color who are interested in learning more?

There are government, faith-based and community advocacy organizations that provide detailed information about clinical trials and why diversity matters. Below are some resources that you may find helpful.

Clinical trials are the primary way we determine whether experimental treatments are safe and effective. Increasing diversity better reflects the range of populations that will use the therapy, or vaccine, being studied. Medications can affect various racial and ethnic groups differently, sometimes to the extent that the U.S. Food and Drug Administration (FDA) recommends separate prescribing instructions.

Clinical trials also provide early access to experimental treatments for a range of diseases. Prioritizing diversity within studies will help ensure people of color are not left out of these potentially lifesaving opportunities and move us closer to a more equitable healthcare system.

How are companies working to increase diversity in clinical trials and protect those who participate?
The biopharmaceutical industry acknowledges past wrongdoings and continues to develop and put in place measures that close gaps in clinical trial representation...
Why do people participate in clinical trials?
All types of people are needed to join clinical trials. 
There are historical cases where people of color were mistreated in clinical trials
Today, all patients and research participants -- including people of color -- are kept safe by law and ethics committees, including Institutional Review Boards (IRB), that oversee clinical trials...